And I think that’s going to continue to be the case because those procedures are growing, et cetera. But as far as where the volume is today, that is in the operating room. And this new tool or series of tools will allow us to directly go after that. So that’s one element is we’ll be playing where the procedures are. The second part is we’ll be able to play at a kind of a lower price point to some extent in that space, which, again, makes it much more competitive to existing procedures and existing budgets that maybe are a little bit more routine, where doctors might say, “Hey, I would love to have the precision of ClearPoint MRI guidance. But for this particular patient, I can probably get away with a little bit maybe less precise, less accurate options.
And certainly, if that’s the type of procedure I can save a little money on and having a lower ASP as a hospital operator, I require that to balance out the overall cost. So this will also allow us to play there. And one of the reasons that allows us to play there is that the workflow is a bit simpler if you’re not worried about communicating to an MRI magnet and adjusting coils for image quality and all those types of things. So what that means is that we would not have to supply a clinical specialist for every single procedure, which brings our overall cost down. So I think in the operating room, you’re going to see more of a model where ClearPoint is there for the first five procedures, the first 10 procedures, something like that. But our clinical sport because of the lower ASP our clinical support starts to roll off over time and we’ll still train on new software and new developments and things like that, but it won’t be a necessity that we have to be there for every case so our clinical team will focus on laser cases and these more complicated MRI procedures and not so much having that added clinical cost in the operating room.
So that’s another very, very key difference. And then the final one I bring up is, in some cases, our system will not require new ClearPoint software to be used, but rather we’ll be able to use our hardware with — our disposable hardware, I mean, alongside other navigation systems that are already in the hospital. So everything I was talking about before of capital budgets and maybe delaying revenue recognition because we do want to do rentals. All of that goes away. If we can just walk in and say, “Hey, here’s a new better mousetrap on the disposable side and it can work with some of the existing hardware and software that’s already in your lab. So we don’t need to even deal with the capital process in that endpoint. So those are kind of the three elements I would point to on the operating room side of thing.
Frank Takkinen: Got it. That’s good color. I’ll stop there. Thanks for taking the questions.
Joe Burnett: Thanks, Frank
Operator: There are no further questions at this time. I would now like to turn the call over to Joe Burnett for closing remarks.
Joe Burnett: Once again, thank you to everyone interested in being a part of this team’s journey here at ClearPoint. This is an exciting time as we plan for new product and service launches across all four of our growth pillars. We’ve worked hard to get to the spot and are incredibly excited for the team, but also for the patients that we hope to treat with new devices and therapies in the very near future. At the end of the day, the patient and their family are why we are here and ultimately, who we are working for. So with that, thank you, and have a good evening.
Operator: I would like to thank our speakers for today’s presentation, and thank you all for joining us. This now concludes today’s call, and you may now disconnect.
